Unicycive Therapeutics Inc: On Sept 19, Co Received A Notice From Nasdaq That Co Is Not In Compliance With $1.00 Minimum Bid Price Requirement
Portfolio Pulse from Benzinga Newsdesk
Unicycive Therapeutics Inc has received a notice from Nasdaq stating that the company is not in compliance with the $1.00 minimum bid price requirement, according to an SEC filing.
September 25, 2023 | 8:23 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Unicycive Therapeutics Inc has received a notice from Nasdaq for not meeting the $1.00 minimum bid price requirement. This could potentially lead to delisting if not rectified.
Unicycive Therapeutics Inc's stock price is below the $1.00 minimum bid price requirement set by Nasdaq. This is a serious issue as it could potentially lead to the company being delisted from the exchange if not rectified within a given timeframe. This news is likely to negatively impact the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100